Innovation & Research

PRICARA®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc will approach Primary Care with unprecedented innovation and commitment to treating it like a specialty.

Ortho-McNeil™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc is a new healthcare company that draws on the rich patient care heritage of its two sister companies, Ortho-McNeil Pharmaceutical®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, and Janssen®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.   Ortho-McNeil strives to provide innovative, high quality, safe, and effective treatments to advance patient care.

With the recent launch of our new unit, PRICARA we have become the only major health care organization in the U.S. focused on Primary Care. PRICARA is dedicated to Primary Care - helping healthcare professionals meet their patient's needs with important medical solutions and patient education that can help identify and address unmet needs in Primary Care. it's called Health Care, but Human Being Care is how we see it.

In the United States, medications developed by Ortho-McNeil or its partners include pain medication, as well as treatments for acid reflux disease and infectious diseases. Ortho-McNeil continues to explore new opportunities to develop solutions for unmet health care needs in Primary Care through its network affiliations, including Johnson & Johnson Pharmaceutical Research & Development, L.L.C., as well as through relationships with academic and private sector research and development, and licensing and acquisition partners.

See News Center for recent announcements regarding these efforts.